Table 2 PESI for PE risk and diagnosis
First author, Year | PESI | Risk | Diagnosis | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
All-cause death | PE-related death | Adverse outcome | All-cause death | PE-related death | Adverse outcome | ||||||||
PESI low risk | PESI high risk | PESI low risk | PESI high risk | PESI low risk | PESI high risk | Sensitivity | Specific | Sensitivity | Specific | Sensitivity | Specific | ||
Lankeit M, 2011 | sPESI | 1/198 (0.5%) | 26/328 (7.9%) | 0/198 (0.0%) | 8/328 (2.4%) | 2/198 (1.0%) | 29/328 (8.8%) | 0.963 | 0.395 | 1.000 | 0.382 | 0.935 | 0.396 |
Sánchez D, 2011 | sPESI | 7/407 (1.7%) | 120/884 (13.6%) | 2/407 (0.5%) | 58/884 (6.6%) | Not mentioned | Not mentioned | 0.945 | 0.344 | 0.967 | 0.329 | N/A | N/A |
Lankeit M, 2012 | sPESI | 0/165 (0.0%) | 40/361 (11.1%) | Not mentioned | Not mentioned | 3/165 (1.8%) | 18/361 (5.0%) | 1.000 | 0.340 | N/A | N/A | 0.857 | 0.321 |
Righini M, 2011 | sPESI | 1/165 (0.9%) | 10/192 (5.2%) | 1/165 (0.9%) | 6/192 (3.0%) | Not mentioned | Not mentioned | 0.909 | 0.474 | 0.857 | 0.469 | N/A | N/A |
Spirk D, 2011 | sPESI | 0/106 (0.0%) | 16/263 (6.1%) | Not mentioned | Not mentioned | 3/106 (2.9%) | 21/263 (8.0%) | 1.000 | 0.394 | N/A | N/A | 0.875 | 0.299 |
Vanni S, 2011 | PESI | 4/145 (2.8%) | 34/318 (10.7%) | 1/145 (0.7%) | 24/318 (7.5%) | 3/145 (2.1%) | 29/318 (9.1%) | 0.895 | 0.332 | 0.960 | 0.329 | 0.906 | 0.329 |
Venetz C, 2011 | PESI | 146/6332 (2.3%) | 1234/9179 (14.1%) | Not mentioned | Not mentioned | 63/6332 (1.0%) | 275/9179 (3.0%) | 0.894 | 0.438 | N/A | N/A | 0.814 | 0.417 |
Venetz C, 2011 | sPESI | 134/5715 (2.7%) | 1236/9816 (13.1%) | Not mentioned | Not mentioned | 69/5715 (1.2%) | 275/9816 (2.8%) | 0.902 | 0.394 | N/A | N/A | 0.799 | 0.372 |
Hariharan P, 2011 | PESI | Not mentioned | Not mentioned | Not mentioned | Not mentioned | 9/109 (8.3%) | 54/136 (39.7%) | N/A | N/A | N/A | N/A | 0.857 | 0.549 |
Jiménez D, 2011 | PESI | Not mentioned | Not mentioned | 1/199 (0.5%) | 36/392 (9.2%) | Not mentioned | Not mentioned | N/A | N/A | 0.973 | 0.357 | N/A | N/A |
Singanayagam A, 2011 | PESI | 1/197 (0.5%) | 22/214 (10.3%) | Not mentioned | Not mentioned | Not mentioned | Not mentioned | 0.957 | 0.505 | N/A | N/A | N/A | N/A |
Jiménez D, 2010 (Derivation Cohort) | PESI | 89/4235 (2.1%) | 857/6119 (14.0%) | Not mentioned | Not mentioned | Not mentioned | Not mentioned | 0.906 | 0.411 | N/A | N/A | N/A | N/A |
Jiménez D, 2010 (Derivation Cohort) | sPESI | 3/305 (1.0%) | 75/690 (10.9%) | Not mentioned | Not mentioned | Not mentioned | Not mentioned | 0.962 | 0.329 | N/A | N/A | N/A | N/A |
Jiménez D, 2010 (RIETE Cohort) | sPESI | 28/2565 (1.1%) | 404/4541 (8.9%) | Not mentioned | Not mentioned | Not mentioned | Not mentioned | 0.935 | 0.380 | N/A | N/A | N/A | N/A |
Sam A, 2011 | PESI | 16/431 (3.7%) | 103/775 (13.3%) | Not mentioned | Not mentioned | Not mentioned | Not mentioned | 0.866 | 0.382 | N/A | N/A | N/A | N/A |
Sam A, 2011 | sPESI | 6/369 (1.6%) | 113/837 (13.5%) | Not mentioned | Not mentioned | 8/369 (2.2%) | 34/837 (4.1%) | 0.950 | 0.334 | N/A | N/A | 0.810 | 0.310 |
Chan CM, 2010 | PESI | 0/106 (0.0%) | 9/196 (4.6%) | Not mentioned | Not mentioned | Not mentioned | Not mentioned | 1.000 | 0.362 | N/A | N/A | N/A | N/A |
Singanayagam A, 2010 | PESI | 6/288 (2.1%) | 38/297 (12.8%) | Not mentioned | Not mentioned | Not mentioned | Not mentioned | 0.864 | 0.521 | N/A | N/A | N/A | N/A |
Moores L, 2010 | PESI | 2/191 (1.0%) | 55/376 (14.6%) | 1/191 (1.5%) | 33/376 (8.8%) | Not mentioned | Not mentioned | 0.965 | 0.371 | 0.971 | 0.356 | N/A | N/A |
Nordenholz K, 2011 | PESI | 0/91 (0.0%) | 5/77 (6.5%) | Not mentioned | Not mentioned | Not mentioned | Not mentioned | 1.000 | 0.588 | N/A | N/A | N/A | N/A |
Choi WH, 2009 | PESI | 3/39 (7.7%) | 13/51 (25.5%) | Not mentioned | Not mentioned | Not mentioned | Not mentioned | 0.813 | 0.486 | N/A | N/A | N/A | N/A |
Donzé J, 2008 | PESI | 2/186 (1.1%) | 19/171 (11.1%) | Not mentioned | Not mentioned | Not mentioned | Not mentioned | 0.905 | 0.548 | N/A | N/A | N/A | N/A |
Jiménez D, 2008 | PESI | 0/100 (0.0%) | 12/218 (5.5%) | Not mentioned | Not mentioned | Not mentioned | Not mentioned | 1.000 | 0.327 | N/A | N/A | N/A | N/A |
Jiménez D, 2007 (Validation Cohort) | PESI | 2/216 (0.9%) | 41/383 (10.7%) | Not mentioned | Not mentioned | 6/216 (2.8%) | 26/383 (6.8%) | 0.953 | 0.385 | N/A | N/A | 0.813 | 0.370 |
Aujesky D, 2007 | PESI | 5/426 (1.2%) | 53/573 (9.2%) | 3/426 (0.7%) | 18/573 (3.1%) | Not mentioned | Not mentioned | 0.914 | 0.447 | 0.857 | 0.433 | N/A | N/A |